Experimental models for the in vivo evaluation of enzyme induction properties of drugs.
D000083:Acetanilides / Q000378:metabolism; D000577:Amides / Q000494:pharmacology; D000632:Aminopyrine / Q000378:metabolism; D000661:Amphetamine / Q000378:metabolism; D000814:Aniline Compounds / Q000378:metabolism; D000818:Animals; D002490:Central Nervous System / Q000187:drug effects; D003061:Codeine / Q000378:metabolism; D003509:Cyclohexanecarboxylic Acids / Q000494:pharmacology*; D004353:Drug Evaluation, Preclinical; D004789:Enzyme Activation / Q000187:drug effects; D004790:Enzyme Induction / Q000187:drug effects*; D006591:Hexobarbital / Q000378:metabolism; D008297:Male; D008614:Meperidine / Q000378:metabolism; D051379:Mice; D010095:Oxotremorine / Q000378:metabolism; D010424:Pentobarbital / Q000378:metabolism; D010615:Phenacetin / Q000378:metabolism; D010672:Phenytoin / Q000378:metabolism; D011817:Rabbits; D051381:Rats; D013331:Strychnine / Q000378:metabolism; D014044:Tolbutamide / Q000378:metabolism; D014203:Tremorine / Q000378:metabolism; D015049:Zoxazolamine / Q000378:metabolism
D000083:Acetanilides; D000577:Amides; D000814:Aniline Compounds; D003509:Cyclohexanecarboxylic Acids; D000632:Aminopyrine; D010095:Oxotremorine; D010672:Phenytoin; D014044:Tolbutamide; D015049:Zoxazolamine; D008614:Meperidine; D006591:Hexobarbital; D000661:Amphetamine; D010615:Phenacetin; D013331:Strychnine; D010424:Pentobarbital; D014203:Tremorine; D003061:Codeine